S×F vari­­ance [General Sta­tis­tics]

posted by AngusMcLean – USA, 2014-12-23 17:32 (3844 d 19:33 ago) – Posting: # 14151
Views: 43,741

Thanks Helmut:

I understand immediately below very well

❝ Regrettably I had too little spare time to dive into. However, some points:

❝ 1. #14138: John is correct that the setup should essentially follow FDA’s code for RSABE. Therefore, anything obtained from ABE is not useful.


But I cannot reconcile it with immediately below, since this pertains to the average BE part of the template so why do it if you are focusing on RSABE?

❝ Modifying the ABE-part doesn’t do the job (see #1 above). What you could do: Copy the entire Prepare Data for RSABE analysis workflow and change the coding in the second one from R to T. Don’t forget to change all filters and transformations. Then you have both the results for R and T. Proceed from there.


Also I had planned on doing the three chi-squared calculations in NCSS described in Part 4 of the new Methylphendiate Guidance (2014). I am puzzled by how you can do this in Phoenix (see below)

❝ Ana’s new templates removed the clumsy workaround for joining values of the χ², since chiinv(p, df) was introduced in PHX/WNL6.4 and can be used in the custom transformation.


Angus

Complete thread:

UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,683 registered users;
37 visitors (0 registered, 37 guests [including 10 identified bots]).
Forum time: 14:06 CEST (Europe/Vienna)

You can do one of two things; just shut up,
which is something I don’t find easy,
or learn an awful lot very fast,
which is what I tried to do.    Jane Fonda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5